相似文献
1
Increases in SLT2 expression and chitin content are associated with incomplete killing of Candida glabrata by caspofungin.
Antimicrob Agents Chemother. 2008 Mar;52(3):1144-6. doi: 10.1128/AAC.01542-07. Epub 2007 Dec 17.
2
The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Murine Model of Candida glabrata Colonization and Systemic Dissemination.
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01412-17. Print 2017 Dec.
3
Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.
Antimicrob Agents Chemother. 2010 Jan;54(1):522-5. doi: 10.1128/AAC.01339-08. Epub 2009 Oct 19.
4
Role of the Slt2 mitogen-activated protein kinase pathway in cell wall integrity and virulence in Candida glabrata.
FEMS Yeast Res. 2010 May;10(3):343-52. doi: 10.1111/j.1567-1364.2010.00611.x. Epub 2010 Feb 3.
5
Elevated chitin content reduces the susceptibility of Candida species to caspofungin.
Antimicrob Agents Chemother. 2013 Jan;57(1):146-54. doi: 10.1128/AAC.01486-12. Epub 2012 Oct 22.
6
Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata.
PLoS Pathog. 2012;8(5):e1002718. doi: 10.1371/journal.ppat.1002718. Epub 2012 May 17.
7
In vitro fungicidal activities of anidulafungin, caspofungin, and micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis evaluated by time-kill studies.
Antimicrob Agents Chemother. 2015;59(6):3615-8. doi: 10.1128/AAC.04474-14. Epub 2015 Mar 23.
8
Dose escalation studies with caspofungin against Candida glabrata.
J Med Microbiol. 2015 Sep;64(9):998-1007. doi: 10.1099/jmm.0.000116. Epub 2015 Jun 30.
9
Candida glabrata mutants demonstrating paradoxical reduced caspofungin susceptibility but increased micafungin susceptibility.
Antimicrob Agents Chemother. 2011 Aug;55(8):3947-9. doi: 10.1128/AAC.00044-11. Epub 2011 May 31.
10
Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.
Antimicrob Agents Chemother. 2008 Oct;52(10):3783-5. doi: 10.1128/AAC.00473-08. Epub 2008 Aug 1.
引用本文的文献
1
Antifungal drug resistance in Candida glabrata: role of cellular signaling and gene regulatory networks.
FEMS Yeast Res. 2025 Jan 30;25. doi: 10.1093/femsyr/foaf025.
2
Review of the novel antifungal drug olorofim (F901318).
BMC Infect Dis. 2024 Nov 7;24(1):1256. doi: 10.1186/s12879-024-10143-3.
3
RNA sequencing reveals a crucial role of Fus3-Kss1 MAPK pathway in pathogenicity.
mSphere. 2024 Nov 21;9(11):e0071524. doi: 10.1128/msphere.00715-24. Epub 2024 Oct 30.
4
Blunted blades: new CRISPR-derived technologies to dissect microbial multi-drug resistance and biofilm formation.
mSphere. 2024 Apr 23;9(4):e0064223. doi: 10.1128/msphere.00642-23. Epub 2024 Mar 21.
5
Functional genetic characterization of stress tolerance and biofilm formation in () via a novel CRISPR activation system.
mSphere. 2024 Feb 28;9(2):e0076123. doi: 10.1128/msphere.00761-23. Epub 2024 Jan 24.
6
P4-ATPase subunit Cdc50 plays a role in yeast budding and cell wall integrity in Candida glabrata.
BMC Microbiol. 2023 Apr 13;23(1):99. doi: 10.1186/s12866-023-02810-3.
7
What 'Omics can tell us about antifungal adaptation.
FEMS Yeast Res. 2022 Jan 11;21(8). doi: 10.1093/femsyr/foab070.
8
Multifactorial Role of Mitochondria in Echinocandin Tolerance Revealed by Transcriptome Analysis of Drug-Tolerant Cells.
mBio. 2021 Aug 31;12(4):e0195921. doi: 10.1128/mBio.01959-21. Epub 2021 Aug 10.
9
Critical Assessment of Cell Wall Integrity Factors Contributing to Echinocandin Tolerance and Resistance in .
Front Microbiol. 2021 Jun 30;12:702779. doi: 10.3389/fmicb.2021.702779. eCollection 2021.
10
Transcriptomic and proteomic profiling revealed reprogramming of carbon metabolism in acetate-grown human pathogen Candida glabrata.
J Biomed Sci. 2021 Jan 2;28(1):1. doi: 10.1186/s12929-020-00700-8.
本文引用的文献
1
Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences.
Antimicrob Agents Chemother. 2007 Jun;51(6):2257-9. doi: 10.1128/AAC.00095-07. Epub 2007 Apr 16.
2
In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera.
Antimicrob Agents Chemother. 2007 May;51(5):1616-20. doi: 10.1128/AAC.00105-07. Epub 2007 Feb 16.
3
The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans.
Mol Microbiol. 2007 Mar;63(5):1399-413. doi: 10.1111/j.1365-2958.2007.05588.x.
4
Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin.
Antimicrob Agents Chemother. 2006 Sep;50(9):3160-1. doi: 10.1128/AAC.00563-06.
5
In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility.
Antimicrob Agents Chemother. 2006 Nov;50(11):3926-8. doi: 10.1128/AAC.00538-06. Epub 2006 Aug 28.
6
Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments.
Antimicrob Agents Chemother. 2006 Jul;50(7):2569-72. doi: 10.1128/AAC.00291-06.
7
Attenuation of the activity of caspofungin at high concentrations against candida albicans: possible role of cell wall integrity and calcineurin pathways.
Antimicrob Agents Chemother. 2005 Dec;49(12):5146-8. doi: 10.1128/AAC.49.12.5146-5148.2005.
8
Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.
Antimicrob Agents Chemother. 2005 Dec;49(12):4989-92. doi: 10.1128/AAC.49.12.4989-4992.2005.
9
Promoter-dependent disruption of genes: simple, rapid, and specific PCR-based method with application to three different yeast.
Curr Genet. 2005 Aug;48(2):117-25. doi: 10.1007/s00294-005-0008-3. Epub 2005 Sep 14.
10
Caspofungin in combination with amphotericin B against Candida glabrata.
Antimicrob Agents Chemother. 2005 Jun;49(6):2546-9. doi: 10.1128/AAC.49.6.2546-2549.2005.
Zotero 插件